FREMONT, Calif., March 4, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, (Nasdaq:WGBS) announced today that will announce fourth quarter and fiscal year 2014 financial results after the market close and host a conference call and webcast on Monday, March 16, 2015.
|Conference Call & Webcast|
|Monday, March 16, 2015 @ 5:00pm Eastern/2:00pm Pacific|
|Replays available until March 30, 2015|
WaferGen Bio-systems, Inc. is a life science company that offers innovative genomic solutions for clinical testing and research. The SmartChip MyDesignTM Real-Time PCR System is a high-throughput genetic analysis platform for profiling and validating molecular biomarkers via microRNA and mRNA gene expression profiling, as well as single nucleotide polymorphism (SNP) genotyping. The SmartChip TETM System is a novel product offering for target enrichment geared towards clinical Next-Gen sequencing (NGS). The Seq-ReadyTM TE System, powered by SmartChip massively-parallel singleplex PCR technology, is an innovative one-step target enrichment and library preparation solution. The Company now also offers the Apollo 324TM product line used in library preparation for NGS. These three complementary technologies offer a powerful set of tools enabling more accurate, faster and cheaper genetic analysis based on Next-Gen Sequencing and Real-Time PCR.
For additional information, please see http://www.wafergen.com
CONTACT: INVESTOR CONTACTS: WaferGen Bio-systems, Inc. Ivan Trifunovich email@example.com (510) 651-4450 LifeSci Advisors, LLC Brian Stollar firstname.lastname@example.orgSource:WaferGen Bio-systems, Inc.